These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7165319)

  • 41. Chronopharmacokinetics of 5-methoxypsoralen.
    Treffel P; Renaud A; Humbert P; Makki S; Faivre B; Agache PG
    Acta Derm Venereol; 1990; 70(6):515-7. PubMed ID: 1981428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Permeation characteristics of 8-methoxypsoralen through human skin; relevance to clinical treatment.
    Anigbogu AN; Williams AC; Barry BW
    J Pharm Pharmacol; 1996 Apr; 48(4):357-66. PubMed ID: 8794983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma levels of 8-methoxypsoralen following oral or bath-water treatment.
    Thomas SE; O'Sullivan J; Balac N
    Br J Dermatol; 1991 Jul; 125(1):56-8. PubMed ID: 1873204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of food on 8-methoxypsoralen serum concentration and minimal phototoxic dose.
    Bech-Thomsen N; Angelo HR; Knudsen EA
    Br J Dermatol; 1992 Dec; 127(6):620-4. PubMed ID: 1476921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The binding of 8-methoxypsoralen by human serum albumin.
    Veronese FM; Bevilacqua R; Schiavon O; Rodighiero G
    Farmaco Sci; 1978 Sep; 33(9):667-75. PubMed ID: 744263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum 8-methoxypsoralen (8-MOP) concentrations after bath water delivery of 8-MOP plus UVA.
    David M; Lowe NJ; Halder RM; Borok M
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):931-2. PubMed ID: 2254480
    [No Abstract]   [Full Text] [Related]  

  • 47. 8-Methoxypsoralen-gas chromatographic determination and serum kinetics.
    Gazith J; Schalla W; Schaefer H
    Arch Dermatol Res; 1978 Nov; 263(2):215-22. PubMed ID: 736606
    [No Abstract]   [Full Text] [Related]  

  • 48. Determination of 8-methoxypsoralen in plasma by electron capture gas chromatography.
    Ehrsson H; Eksborg S; Wallin I; Kållberg N; Swanbeck G
    J Chromatogr; 1977 Oct; 140(2):157-64. PubMed ID: 914909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis.
    Collins P; Rogers S
    Br J Dermatol; 1992 Oct; 127(4):392-5. PubMed ID: 1419760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for uptake of 8-methoxypsoralen and 5-methoxypsoralen by cellular nuclei.
    Sasaki M; Meguro F; Kumazawa E; Fujita H; Kakishima H; Sakata T
    Mutat Res; 1988 Jan; 197(1):51-8. PubMed ID: 3336374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of 3H-8-MOP and its metabolites in rat organs after a single oral administration.
    Wulf HC; Andreasen MP
    J Invest Dermatol; 1981 Apr; 76(4):252-8. PubMed ID: 7205026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid and sensitive analysis of 8-methoxypsoralen in plasma.
    Gasparro FP; Battista J; Song J; Edelson RL
    J Invest Dermatol; 1988 Feb; 90(2):234-6. PubMed ID: 3339265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
    Weber F; Schmuth M; Sepp N; Fritsch P
    Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bath-water delivery of 8-methoxypsoralen therapy for psoriasis.
    Collins P; Rogers S
    Clin Exp Dermatol; 1991 May; 16(3):165-7. PubMed ID: 1934565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Determination of 8-methoxypsoralen in mouse plasma by high performance liquid chromatography and its application to pharmacokinetic study].
    Wu TW; Cui R; Zhang BX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):792-796. PubMed ID: 30337737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic comparison of seven 8-methoxypsoralen brands.
    Menne T; Andersen KE; Larsen E; Solgaard P
    Acta Derm Venereol; 1981; 61(2):137-40. PubMed ID: 6165189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical study of a new preparation of 8-methoxypsoralen in photochemotherapy.
    el-Mofty AM; el-Sawalhy H; el-Mofty M
    Int J Dermatol; 1994 Aug; 33(8):588-92. PubMed ID: 7960360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation.
    Tanew A; Ortel B; Rappersberger K; Hönigsmann H
    J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):333-8. PubMed ID: 3279089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simple equilibrium dialysis-high-performance liquid chromatographic method for the in vitro assessment of 5-methoxypsoralen bound to human albumin.
    Makki S; Muret P; Renaud A; Agache P; Magnin P
    J Chromatogr; 1991 Feb; 539(2):443-8. PubMed ID: 2045454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of 8-methoxypsoralen and blacklight on microorganisms in vitro and in experimental trichophytosis in guinea pigs].
    Oberste-Lehn H; Plempel M
    Dermatologica; 1977; 154(4):193-202. PubMed ID: 863062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.